drugset / Trial / NCT06547151
Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in Adults
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This clinical trial aims to evaluate the efficacy and safety of AMOR-1, consisting of Amorphous Calcium Carbonate (ACC) as the active drug substance, in treating hypocalcemia in adults with hypoparathyroidism.
Timeline
- Start
- 2024-12-15
- Primary completion
- 2026-09
- Completion
- 2026-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amorphous Calcium Carbonate | Unknown | 250 mg | Oral |
| Comparator | Crystalline Calcium Carbonate | Unknown | 500 mg | Oral |